京都大学医学部附属病院 放射線治療科

menu

業績集 1999

2011 | 2010 |
2009 | 2008 | 2007 | 2006 | 2005 | 2004 | 2003 | 2002 | 2001 | 2000 |
1999 | 1998 | 1997 | 1996 | 1995 | 1994 | 1993

1 Nishimura Y., Yokoe Y., Nagata Y., Okajima K., Nishida M. and Hiraoka M.:
High-dose-rate brachytherapy using molds for oralcavity cancer.,
Int. J. Clin. Oncol., 3: 351-56, 1998
2 Teshima T., Ikeda H., Abe M., Hanks G.E., Owen J.B., Oguchi M., Hirokawa Y., Hiraoka M., Nishio M., Yamashita T., Naito A., Okazaki Y., Inoue T.:
Patterns of care study of radiation therapy for utereine cervix cancer in Japan: The influence of age on the process.,
Int. J. Clin. Oncol., 4: 9-16, 1999
3 Yamamoto M., Nagata Y., Okajima K., Ishigaki T., Murata R., Mizowaki T., Kokubo M. and Hiraoka M.:
Differences in target outline delineation from CT scans of brain tumours using different methods and different observers.,
Radiother. Oncol., 50(2):151-56, 1999
4 Nagata Y., Okajima K., Kokubo M., Kanamori S., Fujiwara K., Mizowaki T., Sasai K., Hiraoka M., Kataoka N., Konishi I.:
Clinical results of transcatheter arterial infusion for uterine cervical cancer.,
Am. J. Clin. Oncol., 22(1): 97-102, 1999
5 Tanisada K., Teshima T., Inoue T., Owen J.B., Hanks G.E., Abe M., Ikeda H., Sato S., Kawachi K., Yamashita T., Nishio M., Hiraoka M., Hirokawa Y., Oguchi M. and Masuda K.:
National average for the process of radiation therapy in Japan by Patterns of Care Study.,
Jpn. J. Clin. Oncol., 29(4): 209-13, 1999
6 Kanamori S., Nishimura Y., Kokubo M., Sasai K., Hiraoka M., Shibamoto Y., Hosotani R., Imamura M., Abe M.:
Tumor response and patterns of failure following intraoperative radiotherapy for unresectable pancreatic cancer; Evaluation by computed tomography.,
Acta Oncolologica, 38(2): 215-20, 1999
7 Ishikawa S., Nagata Y., Mitsumori M., Sasai K., Kokubo M., Hiraoka M., Tanaka T., Fukumoto M.:
Primary large cell carcinoma of the submandibular gland.,
Int. J. Clin. Oncol., 4: 189-92, 1999
8 Shibamoto Y., Sasai K., Oya N., Hiraoka M.:
Systemic chemotherapy with vincristine, cyclophophamide, doxorubicin and predonisolone following radiotherapy for primary central nervous system lymphoma: a phase II study.,
J. Neuro-oncol., 42(2): 161-67, 1999
9 Kanamori S., Nishimura Y., Okuno Y., Horii N., Saga T., Hiraoka M.:
Induction of vascular endothelial growth factor (VEGF) by hyperthermia and/or an angiogenesis inhibitor.,
Int. J. of Hyperthermia, 15(4): 267-78, 1999
10 Okuno Y., Nishimura Y., Kashu I., Ono K., Hiraoka M.:
Prognostic values of proliferating cell nuclear antigen(PCNA) and LI-67 for radiotherapy of esophageal squamous cell carcinomas.,
Brit. J. Cancer, 80(3-4): 387-95, 1999
11 Guo G.Z., Sasai K., Oya N., Shibata T., Shibuya K., Hiraoka M.:
A significant correlation between clonogenic radiosensitivity and the simultaneous assessment of micronucleus and apoptotic cell frequencies.,
Int. J. Radiat. Biol., 75(7): 857-864, 1999
12 Nishimura Y., Okuno Y., Ono K., Nagata Y., Hiraoka M.:
External beam radiation therapy with or without high-dose-rate intraluminal brachytherapy for patients with superficial esophageal carcinoma.,
Cancer, 86(2): 220-28, 1999
13 Saitoh H., Nagata Y., Mitsumori M., Kokubo M. and Hiraoka M.:
Angiographic changes in uterine cervical cancer guring the course of transarterial infusion chemotherapy.,
Radiat. Medicine, 17(4): 305-9, 1999
14 Shibuya K., Sasai K., Xie X., Utsumi H., Shibata T., Hiraoka M.:
Detection of hypoxic cells inmurine tumors using the comet assay: comparison with a conventional radiobiological assay.,
Jpn. J. Cancer Res., 90(8): 880-86, 1999
15 Mitsumori M., Hiraoka M., Kodama H.:
Long-term results of postoperative prophylactic irradiation for node-positive, high-risk breast cancer patients.,
Breast Cancer, 6(3): 193-200, 1999
16 Shibuya K., Fujibayashi Y., Yoshimi E., Sasai K., Hiraoka M., Welch M.J.:
Cytosolic/microsomal redox pathway: a reductive retention mechanism of a PET-oncology tracer, Cu-pyruvaldehyde-bis(N4-methylthiosemicarbazone) (Cu-PTSM).,
Ann. Nucl. Med., 13(5): 287-92, 1999
17 Shibamoto Y., Sasai K., Kokubo M., Hiraoka M.:
Salvage radiation therapy for intracranial germinoma recurring after primary chemotherapy.,
J. Neuro-Oncol., 44(2):181-85, 1999
18 Higashi T., Sakahara H., Torizuka T., Nakamoto Y., Kanamori S., Hiraoka M., Imamura M., Nishimura Y., Tamaki N., Konishi J.:
Evaluation of intraoperative radiation therapy for unresectable pancreatic cancer with FDG PET.,
J Nucl Med., 40(9):1424-33, 1999
19 Fujishiro S., Mitsumori M., Kokubo M., Nagata Y., Sasai K., Kodama H., Hiraoka M.:
Evaluation of long-term cosmetic results and complications following breast conseving surgery and radiation therapy for breast cancer.,
J Jpn. Soc. Ther. Radiol. Oncol. 11: 287-94, 1999
20 Shibuya K., Nagata Y., Itoh T., Okajima K., Murata R., Takagi T., Hiraoka M.:
Transcatheter arterial infusion therapy in the treatment of advanced pancreatic cancer: a feasibility study.,
Cardiovasc Intervent Radiol, 22(3): 196-200, 1999
21 Ikeda T., Akiyama F., Hiraoka M., Inaji H., Ohuchi N., Takatsuka Y., Yoshimoto M.:
Surgical Margin Status as a Cause of Local Failure after Breast Conserving Therapy.,
Breast Cancer, 6(2): 93-97, 1999